{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:03:04Z","timestamp":1761897784719,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":251,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.clinsp.2022.100116","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:48:34Z","timestamp":1664585314000},"page":"100116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of oxytocin versus promestriene on genitourinary syndrome: a pilot, prospective, randomized, double-blind study"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-7235","authenticated-orcid":false,"given":"Liani Patricia Andrade","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Em\u00edlio","family":"Bonduki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8642-4135","authenticated-orcid":false,"given":"Rita de C\u00e1ssia de Maio","family":"Dardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-496X","authenticated-orcid":false,"given":"Thais","family":"Heinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa Teresinha","family":"Patriarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinsp.2022.100116_bib0001","series-title":"The 2017 hormone therapy position statement of the North American Menopause Society. Vol. 24, Menopause","first-page":"728","author":"Pinkerton","year":"2017"},{"issue":"3","key":"10.1016\/j.clinsp.2022.100116_bib0002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"79","author":"Portman","year":"2014","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100116_bib0003","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am J Obst Gynecol"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100116_bib0004","first-page":"43","article-title":"Treatment of vaginal atrophy in postmenopausal women","volume":"32","author":"Florencio-Silva","year":"2017","journal-title":"Reprodu\u00e7\u00e3o Climat\u00e9rio"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100116_bib0005","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0002-9378(89)80002-X","article-title":"Biosynthesis and physiologic effects of estrogen and pathophysiologic effects of estrogen deficiency: A review","volume":"161","author":"Utian","year":"1989","journal-title":"Am J Obst Gynecol"},{"key":"10.1016\/j.clinsp.2022.100116_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.03.036","article-title":"Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause","volume":"213","author":"Behnia-Willison","year":"2017","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"10.1016\/j.clinsp.2022.100116_bib0007","first-page":"837","article-title":"The role of androgens in the treatment of Genitourinary Syndrome of Menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review","volume":"25","author":"Simon","year":"2018","journal-title":"Menopause. Lippincott Williams and Wilkins"},{"key":"10.1016\/j.clinsp.2022.100116_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/13697137.2015.1079100","article-title":"Treatment of the genitourinary syndrome of menopause","volume":"18","author":"Palacios","year":"2015","journal-title":"Climaterics"},{"issue":"8","key":"10.1016\/j.clinsp.2022.100116_bib0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/GME.0000000000000903","article-title":"Androgens in postmenopausal women: A review","volume":"24","author":"Shifren","year":"2017","journal-title":"Menopause."},{"issue":"2","key":"10.1016\/j.clinsp.2022.100116_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7257\/1053-816X.2016.36.2.59","article-title":"Genitourinary syndrome of menopause and vaginal estrogen use","volume":"36","author":"Steele","year":"2016","journal-title":"Urol Nurs"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100116_bib0011","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100116_bib0012","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","article-title":"Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment","volume":"30","author":"Zerbinati","year":"2015","journal-title":"Lasers Med Sc"},{"key":"10.1016\/j.clinsp.2022.100116_bib0013","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Lethaby","year":"2016"},{"issue":"7","key":"10.1016\/j.clinsp.2022.100116_bib0014","first-page":"360","article-title":"Promestrieno no tratamento da atrofia vulvovaginal: revis\u00e3o sistem\u00e1tica","volume":"38","author":"Pompei","year":"2010","journal-title":"Femina"},{"key":"10.1016\/j.clinsp.2022.100116_bib0015","first-page":"533","article-title":"Rational use of vaginal promestriene","volume":"9","author":"Aloysio","year":"1995","journal-title":"Ital J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.clinsp.2022.100116_bib0016","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/CAD.0b013e328365288e","article-title":"Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment: Is it safe even in cancer patients?","volume":"24","author":"Del Pup","year":"2013","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100116_bib0017","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1258\/mi.2011.011030","article-title":"Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study","volume":"17","author":"Jonasson","year":"2011","journal-title":"Menopause Int"},{"issue":"3","key":"10.1016\/j.clinsp.2022.100116_bib0018","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2053369115577328","article-title":"Intravaginally applied oxytocin improves post-menopausal vaginal atrophy","volume":"21","author":"Al-Saqi","year":"2015","journal-title":"Post Reprod Health"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100116_bib0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2053369116629042","article-title":"Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women","volume":"22","author":"Al-Saqi","year":"2016","journal-title":"Post Reprod Health"},{"key":"10.1016\/j.clinsp.2022.100116_bib0020","doi-asserted-by":"crossref","unstructured":"Kallak TK, Uvn\u00e4s-Moberg K. Oxytocin stimulates cell proliferation in vaginal cell line Vk2E6E7: Post Reprod Health. 2017;23(1):6-12.","DOI":"10.1177\/2053369117693148"},{"issue":"12","key":"10.1016\/j.clinsp.2022.100116_bib0021","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/jcph.961","article-title":"Population pharmacokinetic analysis of vaginally and intravenously administered oxytocin in postmenopausal women","volume":"57","author":"Nielsen","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100116_bib0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","article-title":"The oxytocin receptor system: structure, function, and regulation","volume":"81","author":"Gimpl","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clinsp.2022.100116_bib0023","first-page":"523","article-title":"A novel biological aspect of ovarian oxytocin: gene expression of oxytocin and oxytocin receptor in cumulus\/luteal cells and the effect of oxytocin on embryogenesis in fertilized oocytes","volume":"395","author":"Furuya","year":"1995","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.clinsp.2022.100116_bib0024","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2826.1990.tb00458.x","article-title":"Regulation of the rat oxytocin gene by estradiol examination of promoter activity in transfected cells and of messenger ribonucleic acid and peptide levels in the hypothalamo-neurohypophyseal system","volume":"2","author":"Peter Burbach","year":"1990","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100116_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0092623X.2020.1738606","article-title":"The impact of oxytocin vaginal gel on sexual function in postmenopausal women: a randomized controlled trial","volume":"46","author":"Abedi","year":"2020","journal-title":"J Sex Marital Therapy"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100116_bib0026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2053369120946645","article-title":"The efficacy and safety of intravaginal oxytocin on vaginal atrophy: a systematic review","volume":"27","author":"Ghorbani","year":"2021","journal-title":"Post Reprod Health"},{"issue":"8","key":"10.1016\/j.clinsp.2022.100116_bib0027","first-page":"396","article-title":"Validation of the female sexual function index in Brazilian pregnant women","volume":"28","author":"Pl\u00e1cido","year":"2007","journal-title":"R Bras Ginecol Obst"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100116_bib0028","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2011","journal-title":"J Sex Marital Therapy"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100116_bib0029","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13697137.2017.1421924","article-title":"Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial","volume":"21","author":"Torky","year":"2018","journal-title":"Climacteric"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:55:32Z","timestamp":1761720932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222033178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"alternative-id":["S1807593222033178"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100116","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of oxytocin versus promestriene on genitourinary syndrome: a pilot, prospective, randomized, double-blind study","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100116"}}